How do endogenous and exogenous stem cell therapies differ in stroke research?
In stroke research, stem cell therapies are categorized into two primary approaches: endogenous and exogenous. These methods differ fundamentally in their source and application.1
Endogenous Stem Cell Therapy
The endogenous approach focuses on stimulating the patientās own neural stem cells (NSCs) already present in the body. Researchers administer growth factorsāsuch as erythropoietin, fibroblast growth factor-2, or brain-derived neurotrophic factorāto induce or enhance neurogenesis. The goal is to activate these dormant cells to repair damaged tissue and promote functional recovery following a stroke.1
Exogenous Stem Cell Therapy
Exogenous therapy involves the extraction, in vitro cultivation, and subsequent transplantation of stem cells into the stroke-affected regions of the brain. These cells may be derived from various sources, including adult NSCs, embryonic stem cells, or hematopoietic stem cells. While grafted cells have shown the ability to differentiate into neurons and glial cells, significant challenges remain. Scientists must still determine how to effectively control the survival, migration, and integration of these transplanted cells into existing neuronal networks, as their behavior is heavily influenced by the specialized microenvironment, or niche, where they reside.1